Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952

Article  CAS  PubMed  Google Scholar 

Ramagopalan SV, Deluca GC, Degenhardt A, Ebers GC (2008) The genetics of clinical outcome in multiple sclerosis. J Neuroimmunol 201-202:183–199

Article  CAS  PubMed  Google Scholar 

Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269

Article  CAS  PubMed  Google Scholar 

Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O (2019) Five decades of cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol 17:129–141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeffery ND, Blakemore WF (1997) Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120(Pt 1):27–37

Article  PubMed  Google Scholar 

Liebetanz D, Merkler D (2006) Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol 202:217–224

Article  CAS  PubMed  Google Scholar 

Franklin RJM, Frisen J, Lyons DA (2021) Revisiting remyelination: towards a consensus on the regeneration of CNS myelin. Semin Cell Dev Biol 116:3–9

Article  PubMed  Google Scholar 

Grinspan JB (2020) Inhibitors of myelination and remyelination, bone morphogenetic proteins, are upregulated in human neurological disease. Neurochem Res 45:656–662

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS (2011) Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J Neurosci 31:4504–4510

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang JK, Fancy SP, Zhao C, Rowitch DH, Ffrench-Constant C, Franklin RJ (2011) Myelin regeneration in multiple sclerosis: targeting endogenous stem cells. Neurotherapeutics 8:650–658

Article  PubMed  PubMed Central  Google Scholar 

Dawson MR, Polito A, Levine JM, Reynolds R (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24:476–488

Article  CAS  PubMed  Google Scholar 

Fernandez-Castaneda A, Gaultier A (2016) Adult oligodendrocyte progenitor cells - multifaceted regulators of the CNS in health and disease. Brain Behav Immun 57:1–7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A (2006) Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26:7907–7918

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez-Perez O, Alvarez-Buylla A (2011) Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev 67:147–156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tognatta R, Miller RH (2016) Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies. Neuropharmacology 110:539–547

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM et al (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211–1218

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lloyd AF, Miron VE (2019) The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol 15:447–458

Article  PubMed  Google Scholar 

Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717

Article  CAS  PubMed  Google Scholar 

Adamo AM, Paez PM, Escobar Cabrera OE, Wolfson M, Franco PG, Pasquini JM, Soto EF (2006) Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin. Exp Neurol 198:519–529

Article  CAS  PubMed  Google Scholar 

Gomez Pinto LI, Rodriguez D, Adamo AM, Mathieu PA (2018) TGF-beta pro-oligodendrogenic effects on adult SVZ progenitor cultures and its interaction with the Notch signaling pathway. Glia 66:396–412

Article  PubMed  Google Scholar 

Mathieu PA, Almeira Gubiani MF, Rodriguez D, Gomez Pinto LI, Calcagno ML, Adamo AM (2019) Demyelination-remyelination in the central nervous system: ligand-dependent participation of the notch signaling pathway. Toxicol Sci 171:172–192

Article  CAS  PubMed  Google Scholar 

Dieu RS, Wais V, Sorensen MZ, Marczynska J, Dubik M, Kavan S, Thomassen M, Burton M, Kruse T, Khorooshi R et al (2021) Central nervous system-endogenous TLR7 and TLR9 induce different immune responses and effects on experimental autoimmune encephalomyelitis. Front Neurosci 15:685645

Article  PubMed  PubMed Central  Google Scholar 

Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, Piesche M, Schroers R, Weiss E, Kirschning CJ et al (2006) Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116:456–464

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marta M (2009) Toll-like receptors in multiple sclerosis mouse experimental models. Ann N Y Acad Sci 1173:458–462

Article  CAS  PubMed  Google Scholar 

Rodriguez JM, Elias F, Flo J, Lopez RA, Zorzopulos J, Montaner AD (2006) Immunostimulatory PyNTTTTGT oligodeoxynucleotides: structural properties and refinement of the active motif. Oligonucleotides 16:275–285

Article  CAS  PubMed  Google Scholar 

Elias F, Flo J, Lopez RA, Zorzopulos J, Montaner A, Rodriguez JM (2003) Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs. J Immunol 171:3697–3704

Article  CAS  PubMed  Google Scholar 

Hernando Insua A, Montaner AD, Rodriguez JM, Elias F, Flo J, Lopez RA, Zorzopulos J, Hofer EL, Chasseing NA (2007) IMT504, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy. Stem Cells 25:1047–1054

Article  PubMed  Google Scholar 

Rodriguez JM, Elias F, Montaner A, Flo J, Lopez RA, Zorzopulos J, Franco RJ, Lenial SP, Lopez Salon M, Pirpignani ML et al (2006) Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells. Medicina 66:9–16

CAS  PubMed  Google Scholar 

Coronel MF, Hernando-Insua A, Rodriguez JM, Elias F, Chasseing NA, Montaner AD, Villar MJ (2008) Oligonucleotide IMT504 reduces neuropathic pain after peripheral nerve injury. Neurosci Lett 444:69–73

Article  CAS  PubMed  Google Scholar 

Leiguarda C, Coronel MF, Montaner AD, Villar MJ, Brumovsky PR (2018) Long-lasting ameliorating effects of the oligodeoxynucleotide IMT504 on mechanical allodynia and hindpaw edema in rats with chronic hindpaw inflammation. Neurosci Lett 666:17–23

Article  CAS  PubMed  Google Scholar 

Leiguarda C, Potilinski C, Rubione J, Tate P, Villar MJ, Montaner A, Bisagno V, Constandil L, Brumovsky PR (2021) IMT504 provides analgesia by modulating cell infiltrate and inflammatory milieu in a chronic pain model. J Neuroimmune Pharmacol 16:651–666

Article  PubMed  Google Scholar 

Chahin A, Opal SM, Zorzopulos J, Jobes DV, Migdady Y, Yamamoto M, Parejo N, Palardy JE, Horn DL (2015) The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis. Antimicrob Agents Chemother 59:1225–1229

Article  PubMed  PubMed Central  Google Scholar 

Hernando-Insua A, Rodriguez JM, Elias F, Flo J, Lopez R, Franco R, Lago N, Zorzopulos J, Montaner AD (2010) A high dose of IMT504, the PyNTTTTGT prototype immunostimulatory oligonucleotide, does not alter embryonic development in rats. Oligonucleotides 20:33–36

Article  CAS  PubMed  Google Scholar 

Franco R, Rodriguez JM, Elias F, Hernando-Insua A, Flo J, Lopez R, Nagle C, Lago N, Zorzopulos J, Horn DL et al (2014) Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide. Nucleic acid therapeutics 24:267–282

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeis T, Enz L, Schaeren-Wiemers N (2016) The immunomodulatory oligodendrocyte. Brain Res 1641:139–148

Article